Home/Filings/4/0000950170-24-067548
4//SEC Filing

Henderson Molly 4

Accession 0000950170-24-067548

CIK 0001783183other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 6:37 PM ET

Size

5.6 KB

Accession

0000950170-24-067548

Insider Transaction Report

Form 4
Period: 2024-05-31
Henderson Molly
CFO and CBO
Transactions
  • Award

    Common Stoock

    2024-05-31+7,500102,763 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,911.27
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Documents

1 file

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1
  • filerCIK 0001363812

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 6:37 PM ET
Size
5.6 KB